Triple-positive breast cancer involves tumors positive for estrogen, progesterone, and HER2 receptors, affecting treatment decisions and strategies. Diagnosis includes imaging and biopsy to confirm ...
EGFR-positive lung cancer is more common in non-smokers (particularly those with adenocarcinoma) and younger adults, as it often develops from a single genetic mutation rather than widespread DNA ...
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced completion of patient enrollment in the company’s Phase 2, ...
HER2 — which stands for human epidermal growth factor receptor 2 — is a type of protein that causes cancer cells to grow more quickly. Tumors that are HER2-positive have higher levels of the HER2 ...
Ontario start-ups attribute early successes to FACIT's continuum of commercialization capital and support TORONTO, April 24, 2026 /PRNewswire/ - The winner of the $100,000 Ernsting Entrepreneurship ...
HER2-positive breast cancer, once associated with poor outcomes, now sees improved prognosis due to targeted therapies like Herceptin. Combination therapies and neoadjuvant treatments have enhanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results